361 Capital’s Phibro Animal Health PAHC Stock Holding History

361 Capital’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-36,778	Closed	-$889K	–	373
2020 Q1	$889K	Buy	+36,778	New	+$899K	0.4%	72

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

361 Capital's PAHC Position: Q2 2020 in Review

361 Capital sold out of Phibro Animal Health (PAHC) in Q2 2020, closing a stake of 36,778 shares — an estimated $889K sold.

361 Capital first reported a position in PAHC in Q1 2020 and held it in 1 quarter. The position peaked at $889K in Q1 2020. 154 funds tracked by Wall St. Rank hold PAHC as of Q2 2020.

361 Capital reported no remaining Phibro Animal Health position as of Q2 2020 after selling out during the quarter.
361 Capital sold 36,778 Phibro Animal Health shares in Q2 2020, an estimated $889K.
361 Capital first reported a position in Phibro Animal Health in Q1 2020 and held it in 1 quarter.
361 Capital's Phibro Animal Health position peaked at $889K in Q1 2020.
154 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.